Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
05/12/17 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
30
05/02/17 DEF 14A Definitive proxy statements 72
05/01/17 8-K Current report filing
Related Documents
42
04/17/17 PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition 67
04/17/17 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 8
04/17/17 8-K Current report filing
Related Documents
56
04/13/17 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
88
04/13/17 8-K Current report filing
Related Documents
5
04/11/17 8-K Current report filing
Related Documents
5
04/07/17 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
10